Literature DB >> 11731955

Chagasic meningoencephalitis in a patient with acquired immunodeficiency syndrome: diagnosis, follow-up, and genetic characterization of Trypanosoma cruzi.

Eliane Lages-Silva1, Luis Eduardo Ramirez, Mario Leon Silva-Vergara, Egler Chiari.   

Abstract

Early diagnosis of the clinical reactivation of Chagas' disease in human immunodeficiency virus- and Trypanosoma cruzi-coinfected persons is fundamental for a good prognosis. Polymerase chain reaction rapidly and efficiently demonstrated the presence and elimination of T. cruzi in the cerebrospinal fluid of a patient with chagasic meningoencephalitis. Characterization of T. cruzi, directly and indirectly in blood and cerebrospinal fluid samples, demonstrated homogeneity of kinetoplast DNA and the presence of lineage 1 (T. cruzi II) in both parasite populations.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11731955     DOI: 10.1086/324355

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  16 in total

1.  Use of the Trypanosoma cruzi recombinant complement regulatory protein to evaluate therapeutic efficacy following treatment of chronic chagasic patients.

Authors:  Wendell S F Meira; Lúcia M C Galvão; Eliane D Gontijo; George L L Machado-Coelho; Karen A Norris; Egler Chiari
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

Review 2.  Adipocyte, adipose tissue, and infectious disease.

Authors:  Mahalia S Desruisseaux; Maria E Trujillo; Herbert B Tanowitz; Philipp E Scherer
Journal:  Infect Immun       Date:  2006-11-21       Impact factor: 3.441

3.  A DTU-dependent blood parasitism and a DTU-independent tissue parasitism during mixed infection of Trypanosoma cruzi in immunosuppressed mice.

Authors:  Helioswilton Sales-Campos; Henrique Borges Kappel; Cristiane Pontes Andrade; Tiago Pereira Lima; Mardén Estevão Mattos; Alessandra de Castilho; Dalmo Correia; Luis Eduardo Ramirez Giraldo; Eliane Lages-Silva
Journal:  Parasitol Res       Date:  2013-11-01       Impact factor: 2.289

4.  Detection of parasitemia profiles by blood culture after treatment of human chronic Trypanosoma cruzi infection.

Authors:  Ana Maria de Castro; Alejandro Ostermayer Luquetti; Anis Rassi; Egler Chiari; Lúcia Maria da Cunha Galvão
Journal:  Parasitol Res       Date:  2006-03-29       Impact factor: 2.289

5.  Trypanosoma cruzi experimental congenital transmission associated with TcV and TcI subpatent maternal parasitemia.

Authors:  Sandra Maria Alkmim-Oliveira; André Guilherme Costa-Martins; Henrique Borges Kappel; Dalmo Correia; Luis Eduardo Ramirez; Eliane Lages-Silva
Journal:  Parasitol Res       Date:  2012-11-18       Impact factor: 2.289

Review 6.  Chagas Disease Diagnostic Applications: Present Knowledge and Future Steps.

Authors:  V Balouz; F Agüero; C A Buscaglia
Journal:  Adv Parasitol       Date:  2016-11-14       Impact factor: 3.870

7.  Protein kinase A catalytic subunit interacts and phosphorylates members of trans-sialidase super-family in Trypanosoma cruzi.

Authors:  Yi Bao; Louis M Weiss; Yan Fen Ma; Stuart Kahn; Huan Huang
Journal:  Microbes Infect       Date:  2010-05-11       Impact factor: 2.700

Review 8.  Between a bug and a hard place: Trypanosoma cruzi genetic diversity and the clinical outcomes of Chagas disease.

Authors:  Louisa A Messenger; Michael A Miles; Caryn Bern
Journal:  Expert Rev Anti Infect Ther       Date:  2015-08       Impact factor: 5.091

9.  Role of protein kinase A in Trypanosoma cruzi.

Authors:  Yi Bao; Louis M Weiss; Vicki L Braunstein; Huan Huang
Journal:  Infect Immun       Date:  2008-08-11       Impact factor: 3.441

10.  The Trypomastigote Small Surface Antigen from Trypanosoma cruzi Improves Treatment Evaluation and Diagnosis in Pediatric Chagas Disease.

Authors:  Virginia Balouz; Luciano J Melli; Romina Volcovich; Guillermo Moscatelli; Samanta Moroni; Nicolás González; Griselda Ballering; Margarita Bisio; Andrés E Ciocchini; Carlos A Buscaglia; Jaime Altcheh
Journal:  J Clin Microbiol       Date:  2017-10-04       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.